Literature DB >> 1653532

Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.

R E Gibson1, H H Thorpe, M E Cartwright, J D Frank, T W Schorn, P B Bunting, P K Siegl.   

Abstract

The angiotensin II (ANG II) receptor has recently been shown to exhibit subtypes with respect to antagonist binding. Of particular interest are the potent nonpeptide antagonists, DUP 753 and PD 121981, which exhibit selectivity for the subtype 1 (AT1) and subtype 2 (AT2) receptors, respectively. We used these high-affinity antagonists in competition with 125I-[Sar1,Ile8]ANG II to determine autoradiographically the distribution of these ANG II-receptor subtypes in the renal cortex of rats and rhesus monkeys. Binding of the radioligand to receptor in sections of rat renal cortex was inhibited by DUP 753; inhibition by PD 121981 was not detected. By contrast, AT1 and AT2 receptors are present in the renal cortex of rhesus monkeys in regionally distinct structures. DUP 753 inhibited binding to the ANG II receptor in glomeruli. PD 121981 inhibited binding to arterial smooth muscle and the juxtaglomerular (JG) apparatus. The JG apparatus also exhibits radioligand binding, which is inhibited by DUP 753. The effect of DUP 753 and PD 123177 (a more water-soluble analogue of PD 121981) on changes in plasma renin activity was examined to determine if one or both of these subtypes participate in the ANG II-mediated negative feedback of control of renin release. Although DUP 753 increased plasma renin activity to the same extent as the angiotensin-converting enzyme inhibitor, enalaprilat, in rats and rhesus monkeys, the AT2 antagonists did not affect renin release in either species. Thus both subtypes of ANG II receptor are present in rhesus monkey cortex, but a function for only the AT1 subtype was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653532     DOI: 10.1152/ajprenal.1991.261.3.F512

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Effect of luminal angiotensin II receptor antagonists on proximal tubule transport.

Authors:  A Quan; M Baum
Journal:  Am J Hypertens       Date:  1999-05       Impact factor: 2.689

Review 2.  The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain.

Authors:  Robert C Speth; Vardan T Karamyan
Journal:  Heart Fail Rev       Date:  2008-01-09       Impact factor: 4.214

3.  Contribution of the renin-angiotensin system to the intrarenal resistive index in chronic unilateral partial ureteral obstruction in dogs.

Authors:  Hiroshi Yokoyama; Yuji Tsuji
Journal:  J Med Ultrason (2001)       Date:  2005-09       Impact factor: 1.314

4.  Fenoterol stimulates human erythropoietin production via activation of the renin angiotensin system.

Authors:  S M Freudenthaler; T Schenck; I Lucht; C H Gleiter
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 5.  Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.

Authors:  Hui Lin; Frank Geurts; Luise Hassler; Daniel Batlle; Katrina M Mirabito Colafella; Kate M Denton; Jia L Zhuo; Xiao C Li; Nirupama Ramkumar; Masahiro Koizumi; Taiji Matsusaka; Akira Nishiyama; Martin J Hoogduijn; Ewout J Hoorn; A H Jan Danser
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

6.  Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.

Authors:  K L Clark; M J Robertson; G M Drew
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

7.  Regulation of blood pressure by the type 1A angiotensin II receptor gene.

Authors:  M Ito; M I Oliverio; P J Mannon; C F Best; N Maeda; O Smithies; T M Coffman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

8.  A pharmacodynamic study of SR 47436, a selective AT1 receptor antagonist, on blood pressure in conscious cynomolgus monkeys.

Authors:  A Roccon; D Marchionni; F Donat; D Segondy; C Cazaubon; D Nisato
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

9.  Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production.

Authors:  Tanya M Gwathmey; Hossam A Shaltout; Karl D Pendergrass; Nancy T Pirro; Jorge P Figueroa; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-25

10.  Commercially available angiotensin II At₂ receptor antibodies are nonspecific.

Authors:  Roman Hafko; Sonia Villapol; Regina Nostramo; Aviva Symes; Esther L Sabban; Tadashi Inagami; Juan M Saavedra
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.